Introduction
Charcot-Marie-Tooth disease (CMT) or hereditary motor and sensory neuropathies are inherited peripheral neuropathies caused by mutations in multiple genes (1) (2) (3) . CMT is a prevalent disorder, with approximately 1 in 2,500 people affected in the general population. CMT is caused by mutations in as many as 50 different genes and is generally divided into type 1 (CMT1) and type 2 (CMT2). CMT1 is primarily a demyelinating neuropathy caused by mutations in peripheral myelin proteins. CMT2 is caused by mutations in genes that affect the peripheral axon. The phenotypes are similar but nerve conduction velocities are reduced in CMT1. In CMT2, the conduction velocities are fairly normal, although compound muscle action potentials are reduced (4, 5) .
Causative mutations have been identified in about 40% of CMT2 patients (6) , although the first CMT2 gene was not identified until 2001. This is the neurofilament light polypeptide gene (NEFL) that encodes neurofilament light polypeptide (NFL), one of the neuronal intermediate filaments (IFs) forming the major cytoskeletal structure of the axon. Neuronal IFs consist of the neurofilament triplet proteins (called NFL, NFM and NFH for neurofilament light, middle and high), -internexin and peripherin (7) . The first NEFL mutations shown to cause CMT2E were dominantly inherited and led to amino acid substitutions in the head domain (P8R) and the rod domain (Q333P, now called Q334P) of NFL (8, 9) . Since then, a total of fourteen mutations in NEFL have been reported in familial and sporadic cases of CMT. Although these mutations are generally considered to cause CMT2E, there are a number of cases of patients with NEFL mutations that resemble CMT1 (8) . In these cases, there was a pronounced slowing in nerve conduction velocity, not generally observed in CMT2. In addition, there are two reports of recessive mutations that cause truncation of the NFL protein resulting in loss of function leading to a severe form of CMT (10, 11) .
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Neurofilaments, like all intermediate filaments are composed of three major domains: an -helical rod domain flanked by N-terminal head and C-terminal tail domains (7) . The -helical rod domain is necessary for the formation of a coiledcoil dimer, which is the first step in intermediate filament assembly. The head domain is generally considered more important for filament formation than the tail domain (12) . The N98S mutation is in the rod domain, and transfection studies have shown that abnormal structures are formed both in the absence and presence of NFM (13) . The P8R mutation is in the head domain and also does not self-assemble into a filamentous network. However, the mutant P8RNFL protein forms abnormal bundled filamentous structures in the presence of NFM in transfected cells (14) . Both the N98S and P8R NFL also disrupt the normal formation of filaments in cultured cells expressing wild type NFL, consistent with the dominant inheritance observed in patients. Neurons from human subjects with other NEFL mutations have been reported to show giant axons, axonal swellings and myelinated fibers consisting exclusively of microtubules with few or absent neuronal IFs (15) . In general, there appears to be a correlation between the effects of CMT2E-associated NFL variants on neuronal IF misassembly when expressed in transfected cells and the reported pathogenicitiy of the corresponding NEFL mutations in patients (13) . The P8R mutation has been described in a number of families with variable ages of onset and severity of symptoms. The N98S mutation is sporadic with an early age of onset (8, 10, 16) .
The first reported N98S patient had an age of onset of less than one year and global developmental delay (8) . In a subsequent study, two cases were reported, one with an age of onset of less than one year and another with an age of onset of less than two years. In addition to delayed walking and gait problems, these two patients both had hearing problems and one also had mental retardation (10).
These previous findings suggest that altered neuronal IF networks contribute to the pathogenic mechanisms leading to CMT2. However, no studies have been or can be done to correlate anatomy or histology with disease onset in humans and by guest on http://hmg.oxfordjournals.org/ Downloaded from there are no published autopsy reports of CMT2E patients. To circumvent this limitation, we have generated knock-in mouse models for CMT2E with the P8R and N98S Nefl mutations.
Results

Generation of Nefl P8R and N98S knock-in mice
We chose to generate mutations in the orthologous mouse Nefl gene using a knock-in strategy (Fig. 1A) . This approach is "physiological" in that the mutant allele is expressed at normal endogenous levels. We obtained multiple founders for the Nefl (Fig. 1D, E) . There was also an approximate 30% decrease in total NFL protein in the brains and spinal cord of the Nefl N98S/+ mice.
The level of total NFL protein levels in the sciatic nerves of the Nefl N98S/+ mice exhibited a decrease of approximately 80% as compared to the WT mice. Since no specific antibodies to the mutant proteins are available, these results only showed differences in total (mutant and wild-type) NFL protein. mice all had normal growth rates and lifespans and were able to reproduce. The Nefl N98S/+ mice showed a noticeable tremor and abnormal hindlimb posture that varied from a hitching motion when lifted by the tail to clasping (Fig. 2 A,B ). There were no differences between male and female animals. More than 85% of the Nefl animals showed the clasping phenotype (Fig. 2C,D) . To determine the age of onset that the animals start to shake and clasp, we pooled the mice at ages 1-3 months, 4-9 months and >9 months and found that the symptoms were already apparent at the earliest age tested and persisted throughout (Fig. 2C,D) . To determine if lack of complete penetrance of the phenotypes was due to the genetic background, we back-crossed the mice with C57Bl/6 wild-type mice more than six generations and tested these animals. For mutant mice of the C57BL/6 background, 97% were shaking, which was higher than 82% of the mice of a mixed background (Fig. 2E ). There was no clear difference in the percentage of animals that were clasping (mixed: 56%; backcrossed: 49%) after backcrossing ( Figure 1) , although the intensity of labeling appeared to be lower in sections from these mice compared to sections from the Nefl +/+ mice, consistent with the somewhat lower levels of total NFL protein (see Fig. 2A,B) .
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Neurofilamentous aggregates in the dorsal root ganglia Immunolabeling of dorsal root ganglia from one year old mice with anti-NFL antibody shows cell body and process labeling in sections from wild-type mice (Fig. 4 A,C) . At high power, the cell body labeling appears to be filamentous (Fig.   4C ). In contrast, the axonal labeling of the Nefl N98S/+ mice was discontinuous and showed the presence of aggregates (Fig. 4B ). In the cell bodies, the labeling pattern also showed discontinuous aggregates (Fig. 4D) . The labeling pattern of NFM was the same as that of NFL ( Supplementary Fig. 2C, D) . Labeling of the axons with NFM was also coincident with the NFL labeling (not shown). Fig. 6 ).
Cerebellar abnormalities in Nefl
Neurofilament number is usually well-correlated with axonal diameter (19, 20) We therefore determined the distribution of the axon area for the Nefl alterations. The Julien laboratory generated mice in which P22S human NFL was expressed under control of a tetracycline responsive gene system (21) . These mice showed aberrant hindlimb posture, hypertrophy of muscle fibers and loss of muscle innervation without neuronal loss. The symptoms were reversible when the mutant gene was turned off, suggesting that therapies aimed at abolishing the abnormal NFL might actually revert the disabilities. However, symptoms were not readily apparent until the mice were nine months of age. Furthermore, expression of human NFL was less than 50% of the endogenous wild type murine NFL whereas in the autosomal dominant human disease one would expect that the mutant protein level would be similar to that of wild type hNFL.
The Garcia laboratory has generated a mouse with an E397K NFL mutant under control of the hNFL promoter (22) . In this mouse, symptoms were first observed at four months, with aberrant hindlimb deformities, reduced locomotor activity and muscle atrophy. Expression of the human NFL variant was also less than 50% of endogenous NFL in this transgenic mouse. No inclusions were observed in either of these two mutant mouse models.
We decided that the best way to model the disease was to use a knock-in strategy, replacing one of the copies of the orthologous mouse Nefl gene with a mutant allele. We focused on two different mutations. The P8R mutation in the head region of the neurofilament protein is one of the first described mutations and has been identified in a number of families. The age of onset of the disease for patients with the P8R mutations is quite variable but usually in the second or third decade of life. In contrast, the N98S mutation in the rod region of NFL has been described only in sporadic cases with an age of onset of less than 2 years.
Consistent with the early age of onset of the human patients with this mutation, the mutant Nefl N98S/+ mice were symptomatic at an early age.
Similar to human patients with the N98S mutation, the symptoms in the Nefl However, the severity of symptoms in humans vary considerably, so it is likely that genetic background will play a role in the severity of the symptoms seen in mice. Furthermore, additional behavioral assays may reveal abnormalities that we have not observed with our limited assays. One other surprising result is that the phenotype of the Nefl N98S/+ mice did not progress in severity with further aging.
One simple possibility is that the mice live in a rather stress-free environment and that they would do worse in other tests. We have also not quantified neuronal death in these animals as they age. One should further note, that NFL knock-out mice have quite a mild phenotype and a normal lifespan. In fact, the Nefl 
Materials and Methods
Generation of Nefl P8R and N98S knock-in mice
We used recombination-mediated genetic engineering or recombineering to construct vectors for manipulation of the mouse genome arbitrary units using ImageJ. NFL protein levels were calculated as a ratio between NFL blot signal and the loading control (GAPDH). These ratios were then normalized to WT levels and averaged across gels. Protein samples were collected from 2 sets of mice and run on gels in triplicate. (Brain: WT: n=10; P8RHet: n=9; P8RHomo: n=10; N98S: n=9; Spinal Cord: WT: n=10; P8RHet: n=9; P8RHomo: n=10; N98S: n=9; Sciatic Nerve: WT: n=9; P8RHet: n=8; P8RHomo: n=9; N98S: n=7). Significance was calculated using a 1-tailed, type 3 T-test in excel (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001).
Antibodies
A rabbit polyclonal anti-NFL antibody was previously generated against a 20 amino acid synthetic peptide corresponding to the N-terminus of NFL (anti-NFL-N) (33). The specificity of the labeling was verified using a monoclonal anti-NFL by guest on 
